Jerrold Sendrow - 29 Jan 2024 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Jerrold Sendrow
Issuer symbol
VRPX
Transactions as of
29 Jan 2024
Net transactions value
$0
Form type
4
Filing time
31 Jan 2024, 16:23:27 UTC
Previous filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 29 Jan 2024 Common Stock 25,000 $0.3178 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis for 12 months commencing one year after the date of grant.

Remarks:

Exhibit 24.1 - Power of Attorney (Jerrold Sendrow)